MusclePharm Corp
OTC:MSLPQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its Industry Average (1.2), the stock would be worth $-0.01 (524% downside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.3 | $0 |
0%
|
| Industry Average | 1.2 | $-0.01 |
-524%
|
| Country Average | 1.5 | $-0.01 |
-637%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
MusclePharm Corp
OTC:MSLPQ
|
34.3 USD | -0.3 | -0 | |
| FR |
|
L'Oreal SA
PAR:OR
|
195.4B EUR | 4.3 | 31.9 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
96.1B GBP | 2.6 | 11.7 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.3T INR | 8.7 | 36.4 | |
| UK |
|
HALEON PLC
LSE:HLN
|
30.6B GBP | 1.3 | 18.4 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
27.7B USD | 2.1 | -160.5 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.5B EUR | 1.7 | 16.5 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 1.9 | 22.1 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 7.4 | 59.9 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | 13 371.8 | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
783.1B INR | 7.8 | 42.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.9 |
| Median | 1.5 |
| 70th Percentile | 2.9 |
| Max | 566 432.7 |
Other Multiples
MusclePharm Corp
Glance View
MusclePharm Corp. engages in the development, manufacture, and distribution of branded sports nutrition products and nutritional supplements. The company is headquartered in Burbank, California. The company went IPO on 2008-12-03. The firm develops, manufactures, markets and distributes branded sports nutrition products and nutritional supplements. The firm's portfolio of brands includes MusclePharm and FitMiss. The MusclePharm brand product portfolio is designed for athletes of all levels and anyone who pursues an active lifestyle. The company offers a range of performance powders, capsules, tablets and gels. Its portfolio of products targets every type of fitness enthusiast and professional, from combat sport, weight training, bodybuilding, running, and all team and individual sports, as well as individuals who lead an active lifestyle. Its offerings are clinically developed through a six-stage research process. The company provides its products under various categories, such as Sport Series, Essentials Series, Natural Series, FitMiss and On-the-Go. Its retail distribution channels include specialty, international and food, drug, and mass (FDM).
